Treace Sees FY24 Revenue $220M-$225M vs $223.16M Est.
Portfolio Pulse from Benzinga Newsdesk
Treace Medical Concepts Inc. (TMCI) forecasts its FY24 revenue to be in the range of $220M-$225M, which is around the analyst estimate of $223.16M.

February 27, 2024 | 10:26 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Treace Medical Concepts Inc. projects its FY24 revenue to be between $220M-$225M, closely aligning with the analyst estimate of $223.16M.
The forecasted revenue range provided by Treace Medical Concepts Inc. closely matches the analyst estimates, indicating a positive outlook on the company's financial performance. This alignment with expectations suggests a stable financial future and may positively influence investor sentiment, potentially leading to an uptick in stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100